JMJD6 and ovarian cancer: It is surprising to note that SKLB325, which inhibits the activity of arginine demethylases, JMJD6, has been found to suppress cell proliferation, induce apoptosis, enable antitumor activities, and display effectiveness in the treatment of ovarian cancer [49,170].